Page 13 of 15 · 351 questions tagged vendor-comparison.
The specifics, since they change the answer: MKM · Tianjin Finder Chemical. I am trying to choose between two options that are usually discussed as though only one…
Conditions: CPC · Hangzhou · Poland. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the plan…
The specifics, since they change the answer: QYB · Chengdu · the United States. I would like to define my thresholds before I have a result, for obvious reasons. I…
Concretely: Homopeptide · Wuxi · the United Kingdom. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan…
Conditions: Homopeptide · Sangon Biotech (Shanghai). These are treated as interchangeable and I do not think they are. If both are acceptable I would like to know…
The case in front of me: QST · Sangon Biotech (Shanghai). These are treated as interchangeable and I do not think they are. If both are acceptable I would like to…
Setup, so nobody has to ask: WXT · KP · New Zealand. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain…
The case in front of me: CPC · Sangon Biotech (Shanghai). I would like the axes of comparison first and the recommendation second. I have tried the first option and…
Details up front: JEEP · ERP · Germany. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible reason…
Stated plainly: WXT · ChinaPeptides (QYAOBIO). I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can obtain either…
What I am working with: ERP · Nantong Guangyuan Chemical. I suspect the honest answer is that it depends, in which case I would like to know on what. Assume I can…
Numbers first: JEEP · Bachem Holding (Suzhou). I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible…
This is a first order from this supplier, so I have no track record to reason from. Both of these get recommended confidently by different people, which suggests…
Details up front: SGN · ERP · Norway. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
Numbers first: WWB · Bachem Holding (Suzhou). I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
For reference: SSA · Wuhan · the United States. I would like to define my thresholds before I have a result, for obvious reasons. I want a plan with explicit stopping…
What I have: a GLP-1 receptor agonist · 10 mg. I can do the algebra. I am not confident about the conversion factors. If there is a standard way to lay this out, I…
Numbers first: KP · WuXi TIDES. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible reason than a…
The particulars: QYB · Homopeptide · Sweden. I am trying to choose between two options that are usually discussed as though only one exists. I am not optimising for…
Numbers first: SGN · Suzhou · Germany. This is a planning question. I know what my options are; I do not know how to weigh them. What I want is the minimum viable…
Setup, so nobody has to ask: FGP · SGN · South Africa. Both of these get recommended confidently by different people, which suggests neither is obviously right. My…
Stated plainly: WXT · SGN · South Africa. Both of these get recommended confidently by different people, which suggests neither is obviously right. My constraints are…
The case in front of me: VendorInvestigate · GL Biochem. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading…
Conditions: Homopeptide · Wuxi · Poland. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the…